PLATELET AGGREGATION INHIBITORS
Clinical trials for PLATELET AGGREGATION INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new PLATELET AGGREGATION INHIBITORS trials appear
Sign up with your email to follow new studies for PLATELET AGGREGATION INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could one blood thinner be safer than two for older heart patients?
Disease control Recruiting nowThis study looks at whether using just one blood thinner (single antiplatelet therapy) is safer and as effective as using two (dual antiplatelet therapy) in older adults or those at high risk of bleeding who have had a heart procedure with a drug-coated balloon. About 576 partici…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: NA • Sponsor: Fondazione Ricerca e Innovazione Cardiovascolare ETS • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Smart algorithm could cut bleeding and clot risks after stent surgery
Disease control Recruiting nowThis study tests whether a personalized risk-score algorithm can better determine how long patients should take two blood thinners after getting a heart stent. About 2,788 adults receiving a drug-coated stent will be assigned to either algorithm-guided or standard treatment durat…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: NA • Sponsor: Insel Gruppe AG, University Hospital Bern • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Can a simple aspirin switch save lives? new study tests best dose for diabetics
Knowledge-focused Recruiting nowThis study looks at how well different forms and doses of daily aspirin work in people with type 2 diabetes to prevent blood clots. About 30 participants will first take a standard coated aspirin for a week. Those whose blood does not respond well will then try three other aspiri…
Matched conditions: PLATELET AGGREGATION INHIBITORS
Phase: PHASE1 • Sponsor: Montreal Heart Institute • Aim: Knowledge-focused
Last updated May 13, 2026 16:03 UTC